A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells. The gene discussed is TGFBR2; the disease is non-small cell lung carcinoma.